Creating a new survey to detect nerve damage from chemotherapy in young children
Development of a novel survey to screen for chemotherapy-induced peripheral neuropathy in young children
This study is creating a new survey to help find out if young children with leukemia are experiencing nerve pain from their chemotherapy, so we can better support their health and well-being after treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10981754 on NIH RePORTER |
What this research studies
This research aims to develop a novel survey that will help identify chemotherapy-induced peripheral neuropathy (CIPN) in young children, particularly those undergoing treatment for acute lymphoblastic leukemia. The project will involve training in qualitative research and survey development, allowing the principal investigator to create a reliable tool for screening this debilitating side effect. By collaborating with a multidisciplinary team, the research will focus on understanding the symptoms and impacts of CIPN on children's development and quality of life. The ultimate goal is to improve the health outcomes for childhood cancer survivors by implementing effective screening methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are receiving or have received chemotherapy for cancer, particularly acute lymphoblastic leukemia.
Not a fit: Patients who are not undergoing chemotherapy or who are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better detection and management of nerve damage in children undergoing cancer treatment, improving their long-term health and quality of life.
How similar studies have performed: Previous research has shown success in developing screening tools for treatment-related side effects in pediatric populations, indicating that this approach has potential.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Rodwin, Rozalyn — Yale University
- Study coordinator: Rodwin, Rozalyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.